跳至主要内容
临床试验/NCT04765423
NCT04765423撤回不适用

[F-18] Fluciclovine (Axumin) PET/CT vs. [F-18] NaF PET/CT in the Evaluation of Prostate Cancer Osseous Metastatic Disease

Case Comprehensive Cancer Center2 个研究点 分布在 1 个国家开始时间: 2021年3月25日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Area under the curve (AUC)

研究概览

简要总结

The purpose of this study is to look at whether F-18 Fluciclovine (i.e. Axumin) is better or as good as F-18 Sodium Fluoride (F-18 NaF) when looking at bone disease from prostate cancer. Axumin is a radioactive agent used on a positron/computed tomography (PET/CT) camera to look for prostate cancer in general.

详细描述

The study will assess the diagnostic performance of [F-18] fluciclovine PET/CT compared to [F-18] NaF PET/CT as the reference standard. Each bone lesion identified on [F-18] NaF PET/CT will be compared with the level of [F-18] fluciclovine uptake

The primary objective is to assess [F-18] fluciclovine efficacy in the evaluation of osseous metastatic disease in prostate cancer on a lesion-by-lesion comparison with [F-18] NaF as a the reference standard.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Referred for initial staging or restaging of prostate cancers with clinical suspicion of bone metastases.
  • Must understand and voluntarily sign an Informed Consent Document

排除标准

  • Cannot tolerate imaging up to 60 minutes of total imaging

结局指标

主要结局

Area under the curve (AUC)

时间窗: At time of scan, up to 60 minutes per scan

Accuracy of \[F-18\] fluciclovine PET/CT compared to \[F-18\] NaF PET/CT evaluated via AUC using Receiver Operating Characteristic (ROC) curves

Number of lesions seen by [F-18] NaF PET/CT which are also seen by [F-18] fluciclovine PET/CT

时间窗: At time of scan, up to 60 minutes per scan

Agreement of imaging methods as measured by number of lesions seen by \[F-18\] NaF PET/CT which are also seen by \[F-18\] fluciclovine PET/CT broken down by diagnostic score on a lesion-by-lesion basis (1 to 5) 1. Definitely benign 2. Probably benign 3. Equivocal 4. Probably malignant 5. Definitely malignant

Sensitivity

时间窗: At time of scan, up to 60 minutes per scan

Accuracy of \[F-18\] fluciclovine PET/CT compared to \[F-18\] NaF PET/CT evaluated via sensitivity Sensitivity is the number of true positives (TP) divided by the sum of TP and false negatives (FN): Sensitivity = TP / (TP+FN)

Positive Predictive Value (PPV)

时间窗: At time of scan, up to 60 minutes per scan

Accuracy of \[F-18\] fluciclovine PET/CT compared to \[F-18\] NaF PET/CT evaluated via PPV PPV is the number of true TP divided by the sum of TP and FP: Sensitivity = TP / (TP+FP)

Specificity

时间窗: At time of scan, up to 60 minutes per scan

Accuracy of \[F-18\] fluciclovine PET/CT compared to \[F-18\] NaF PET/CT evaluated via specificity Specificity is the number of true Negatives (TN) divided by the sum of TN and false positives (FP): Sensitivity = TN / (TN+FP)

Negative Predictive Value (NPV)

时间窗: At time of scan, up to 60 minutes per scan

Accuracy of \[F-18\] fluciclovine PET/CT compared to \[F-18\] NaF PET/CT evaluated via NPV NPV is the number of true TN divided by the sum of TN and FN: Sensitivity = TN / (TN+FN)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in... | 临床试验